Chimeric antigen receptor T-cell (CAR-T) cell therapy in Hungary in paediatric acute lymphoblastic leukaemia (ALL) and adult diffuse large B-cell lymphoma (DLBCL) disorders (Q3911376): Difference between revisions
Jump to navigation
Jump to search
(Changed label, description and/or aliases in nl: Adding Dutch translations) |
(Changed label, description and/or aliases in it: Adding Italian translations) |
||
| label / it | label / it | ||
Terapia cellulare a cellule T (CAR-T) del recettore chimerico dell'antigene in Ungheria nei disturbi della leucemia linfoblastica acuta pediatrica (ALL) e del linfoma a grandi cellule B (DLBCL) diffuso negli adulti | |||
Revision as of 07:35, 14 January 2022
Project Q3911376 in Hungary
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Chimeric antigen receptor T-cell (CAR-T) cell therapy in Hungary in paediatric acute lymphoblastic leukaemia (ALL) and adult diffuse large B-cell lymphoma (DLBCL) disorders |
Project Q3911376 in Hungary |
Statements
1,299,400,748 forint
0 references
3,739,026.473 Euro
0.0027336256 Euro
14 December 2021
0 references
1,367,790,261.053 forint
0 references
94.999998 percent
0 references
1 February 2021
0 references
1 February 2023
0 references
DÉL-PESTI CENTRUMKÓRHÁZ-ORSZÁGOS HEMATOLÓGIAI ÉS INFEKTOLÓGIAI INTÉZET
0 references
47°29'30.62"N, 18°58'44.15"E
0 references
Budapest, Budapest
0 references
Identifiers
EFOP-5.2.6-20-2020-00010
0 references